Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward L Murphy

Showing results (51-60 of 164) with videos related to

Pageof 17
Sort By:
Transfusion|March 15, 2006
Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donorsMichael P Busch, Simone A Glynn, Susan L Stramer, et al.
BMC Pulmonary Medicine|July 30, 2003
Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort studyEdward L Murphy, Helen E Ownby, James W Smith, et al.
American Journal of Epidemiology|January 22, 2008
Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donorsAnne M Guiltinan, Zhanna Kaidarova, Brian Custer, et al.
Emerging Infectious Diseases|August 19, 2017
Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South AfricaMarion Vermeulen, Ronel Swanevelder, Dhuly Chowdhury, et al.
The Journal of Infectious Diseases|November 4, 2006
Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical dataNicholas Kwaan, Tzong-Hae Lee, Daniel M Chafets, et al.
JAMA|May 8, 2003
Effect of a national disaster on blood supply and safety: the September 11 experienceSimone A Glynn, Michael P Busch, George B Schreiber, et al.
The Journal of Infectious Diseases|September 27, 2013
Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009Yun Brenda Chang, Zhanna Kaidarova, Daniel Hindes, et al.
Frontiers in Immunology|March 26, 2021
Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 InfectionDanielle M Clements, Brenndan Crumley, Glen M Chew, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 8, 2021
Trends in serological markers of transfusion transmissible infections in blood donations at the Bamenda Hospital-based Blood Service, CameroonMoses Samje, Victor N Fondoh, Georges Nguefack-Tsague, et al.
Transfusion|May 5, 2012
Major depression and generalized anxiety disorder among human T-lymphotropic virus types I- and II-infected former blood donorsAnne M Guiltinan, Zhanna Kaidarova, Dee Behan, et al.
Pageof 17

Showing results (51-60 of 164) with videos related to

Sort By:
Pageof 17
Transfusion|March 15, 2006
Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donorsMichael P Busch, Simone A Glynn, Susan L Stramer, et al.
BMC Pulmonary Medicine|July 30, 2003
Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort studyEdward L Murphy, Helen E Ownby, James W Smith, et al.
American Journal of Epidemiology|January 22, 2008
Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donorsAnne M Guiltinan, Zhanna Kaidarova, Brian Custer, et al.
Emerging Infectious Diseases|August 19, 2017
Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South AfricaMarion Vermeulen, Ronel Swanevelder, Dhuly Chowdhury, et al.
The Journal of Infectious Diseases|November 4, 2006
Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical dataNicholas Kwaan, Tzong-Hae Lee, Daniel M Chafets, et al.
JAMA|May 8, 2003
Effect of a national disaster on blood supply and safety: the September 11 experienceSimone A Glynn, Michael P Busch, George B Schreiber, et al.
The Journal of Infectious Diseases|September 27, 2013
Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009Yun Brenda Chang, Zhanna Kaidarova, Daniel Hindes, et al.
Frontiers in Immunology|March 26, 2021
Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 InfectionDanielle M Clements, Brenndan Crumley, Glen M Chew, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 8, 2021
Trends in serological markers of transfusion transmissible infections in blood donations at the Bamenda Hospital-based Blood Service, CameroonMoses Samje, Victor N Fondoh, Georges Nguefack-Tsague, et al.
Transfusion|May 5, 2012
Major depression and generalized anxiety disorder among human T-lymphotropic virus types I- and II-infected former blood donorsAnne M Guiltinan, Zhanna Kaidarova, Dee Behan, et al.
Pageof 17